DES

DEVICE6 trials

Sponsors

Svelte Medical Systems, Inc., Beijing Hospital, Peking University Third Hospital, M.A. Med Alliance S.A., Henan Institute of Cardiovascular Epidemiology

Conditions

Acute Coronary SyndromeCoronary Artery DiseaseCoronary DiseaseCoronary Heart Disease

Unknown Phase

OPTIMIZE IDE for the Treatment of ACS

TerminatedNCT03190473

Svelte Medical Systems, Inc.Acute Coronary Syndrome

Start: 2018-01-02End: 2023-03-08Updated: 2023-03-23

Clinical Trial on Safety and Efficacy of Drug-coated Balloon in Treatment of Coronary Bifurcation Lesions

CompletedNCT03223974

Beijing HospitalCoronary Disease

Start: 2017-11-16End: 2021-02-28Updated: 2022-03-22

Comparative Clinical Study of Drug-coating Balloon Strategy and Drug-eluting Stent Strategy

Peking University Third HospitalCoronary Artery Disease

Start: 2021-06-30End: 2025-06-30Target: 1000Updated: 2021-04-13

The SELUTION DeNovo Study

Active, not recruitingNCT04859985

M.A. Med Alliance S.A.Coronary Artery Disease

Start: 2021-05-15End: 2030-10-31Updated: 2026-01-22

Comparison of DCB and DES for Severe Calcification of de Novo Lesion in Elderly CHD

CompletedNCT05750771

Henan Institute of Cardiovascular EpidemiologyCoronary Artery Disease

Start: 2023-02-20End: 2025-08-01Updated: 2026-04-06

A Cohort Study of PCI Strategies for Severely Calcified Lesions of Complex Coronary Arteries in the Elderly

RecruitingNCT06168422

Henan Institute of Cardiovascular EpidemiologyCoronary Heart Disease

Start: 2023-12-25End: 2025-05-06Target: 2100Updated: 2024-06-27

Related Papers

Safety and Effectiveness of the SVELTE Fixed-Wire and Rapid Exchange Bioresorbable-Polymer Sirolimus-Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions: Results of the OPTIMIZE Randomized Study

Circulation Cardiovascular Interventions2021-08-069 citations